PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
HQY vs. JPM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between HQY and JPM is 0.33, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

HQY vs. JPM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in HealthEquity, Inc. (HQY) and JPMorgan Chase & Co. (JPM). The values are adjusted to include any dividend payments, if applicable.

0.00%10.00%20.00%30.00%40.00%50.00%SeptemberOctoberNovemberDecember2025February
53.15%
31.98%
HQY
JPM

Key characteristics

Sharpe Ratio

HQY:

1.30

JPM:

2.64

Sortino Ratio

HQY:

1.85

JPM:

3.41

Omega Ratio

HQY:

1.25

JPM:

1.52

Calmar Ratio

HQY:

1.27

JPM:

6.19

Martin Ratio

HQY:

5.71

JPM:

17.68

Ulcer Index

HQY:

7.18%

JPM:

3.54%

Daily Std Dev

HQY:

31.68%

JPM:

23.78%

Max Drawdown

HQY:

-60.65%

JPM:

-74.02%

Current Drawdown

HQY:

-1.11%

JPM:

0.00%

Fundamentals

Market Cap

HQY:

$9.81B

JPM:

$782.77B

EPS

HQY:

$1.09

JPM:

$19.75

PE Ratio

HQY:

103.89

JPM:

14.17

PEG Ratio

HQY:

1.24

JPM:

7.52

Total Revenue (TTM)

HQY:

$887.96M

JPM:

$177.39B

Gross Profit (TTM)

HQY:

$531.69M

JPM:

$177.39B

EBITDA (TTM)

HQY:

$254.72M

JPM:

$118.91B

Returns By Period

The year-to-date returns for both stocks are quite close, with HQY having a 18.02% return and JPM slightly lower at 17.39%. Both investments have delivered pretty close results over the past 10 years, with HQY having a 19.34% annualized return and JPM not far ahead at 20.01%.


HQY

YTD

18.02%

1M

10.56%

6M

53.15%

1Y

39.30%

5Y*

5.46%

10Y*

19.34%

JPM

YTD

17.39%

1M

8.02%

6M

31.98%

1Y

59.95%

5Y*

18.71%

10Y*

20.01%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

HQY vs. JPM — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HQY
The Risk-Adjusted Performance Rank of HQY is 7979
Overall Rank
The Sharpe Ratio Rank of HQY is 8282
Sharpe Ratio Rank
The Sortino Ratio Rank of HQY is 7676
Sortino Ratio Rank
The Omega Ratio Rank of HQY is 7575
Omega Ratio Rank
The Calmar Ratio Rank of HQY is 8282
Calmar Ratio Rank
The Martin Ratio Rank of HQY is 8282
Martin Ratio Rank

JPM
The Risk-Adjusted Performance Rank of JPM is 9696
Overall Rank
The Sharpe Ratio Rank of JPM is 9696
Sharpe Ratio Rank
The Sortino Ratio Rank of JPM is 9393
Sortino Ratio Rank
The Omega Ratio Rank of JPM is 9595
Omega Ratio Rank
The Calmar Ratio Rank of JPM is 9898
Calmar Ratio Rank
The Martin Ratio Rank of JPM is 9696
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

HQY vs. JPM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for HealthEquity, Inc. (HQY) and JPMorgan Chase & Co. (JPM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for HQY, currently valued at 1.30, compared to the broader market-2.000.002.004.001.302.64
The chart of Sortino ratio for HQY, currently valued at 1.85, compared to the broader market-6.00-4.00-2.000.002.004.006.001.853.41
The chart of Omega ratio for HQY, currently valued at 1.25, compared to the broader market0.501.001.502.001.251.52
The chart of Calmar ratio for HQY, currently valued at 1.27, compared to the broader market0.002.004.006.001.276.19
The chart of Martin ratio for HQY, currently valued at 5.71, compared to the broader market0.0010.0020.0030.005.7117.68
HQY
JPM

The current HQY Sharpe Ratio is 1.30, which is lower than the JPM Sharpe Ratio of 2.64. The chart below compares the historical Sharpe Ratios of HQY and JPM, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50SeptemberOctoberNovemberDecember2025February
1.30
2.64
HQY
JPM

Dividends

HQY vs. JPM - Dividend Comparison

HQY has not paid dividends to shareholders, while JPM's dividend yield for the trailing twelve months is around 1.71%.


TTM20242023202220212020201920182017201620152014
HQY
HealthEquity, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
JPM
JPMorgan Chase & Co.
1.71%1.92%2.38%2.98%2.34%2.83%2.37%2.54%1.91%2.13%2.54%2.49%

Drawdowns

HQY vs. JPM - Drawdown Comparison

The maximum HQY drawdown since its inception was -60.65%, smaller than the maximum JPM drawdown of -74.02%. Use the drawdown chart below to compare losses from any high point for HQY and JPM. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-1.11%
0
HQY
JPM

Volatility

HQY vs. JPM - Volatility Comparison

HealthEquity, Inc. (HQY) has a higher volatility of 6.19% compared to JPMorgan Chase & Co. (JPM) at 4.28%. This indicates that HQY's price experiences larger fluctuations and is considered to be riskier than JPM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%SeptemberOctoberNovemberDecember2025February
6.19%
4.28%
HQY
JPM

Financials

HQY vs. JPM - Financials Comparison

This section allows you to compare key financial metrics between HealthEquity, Inc. and JPMorgan Chase & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab